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ABSTRACT 
Though microaneurysms are the hallmark of diabetic retinopathy (DR), large aneurismal changes termed as 
''macroaneurysms'' (MAs) may also occur in the course of chronic diabetic macular edema. MAs are usually accompanied 
by intraretinal hard exudates, fluid accumulation and retinal hemorrhages. Detection of MAs is clinically important as it 
implies that macular edema is usually chronic and therefore can be resistant to intravitreal anti-vascular endothelial 
growth factor injections. Multimodal imaging consisting of fluorescein angiography (FA), indocyanine green angiography 
(ICGA), optical coherence tomography (OCT) or OCT-angiography (OCTA) can be performed to detect and understand the 
nature of MA and thereby select proper treatment modality. Herein, we report multimodal imaging features of a 64-
year-old woman with insulin-dependent diabetes mellitus presented with treatment naïve severe macular edema and a 
macroaneurysm at the right temporal macula. In conclusion, FA, ICGA and OCT seem to be far superior to OCTA to detect 
these lesions due to probable slow flow inside the MA. 
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INTRODUCTION
Microaneurysms, hard exudates, dot or blot 
hemorrhages, macular edema, capillary occlusion, 
cotton-wool spots and neovascularization are among 
the clinical features of diabetic retinopathy (DR) [1].
 
Though the presence of microaneurysms is the clinical 
hallmark of DR, a few of the recent studies have 
reported that  macroaneurysms (MAs) may also occur 
during the course of DR [2-4].
 
Retinal findings can be 
marked when MA is ruptured as the consequence of 
focal destruction of inner blood-retinal barrier. MAs 
may not be recognized on fundus examination or 
fluorescein angiography (FA). Therefore, other imaging 
methods such as indocyanine green angiography 
(ICGA) optical coherence tomography (OCT) and OCT-
 
 
Med Hypothesis Discov Innov Ophthalmol. 2020; 9(1)  
34 MULTIMODAL IMAGING CHARACTERISTICS OF   CAPILLARY MACROANEURYSM IN DIABETIC CASE 
angiography (OCTA) may be required to detect MAs 
and understand the underlying pathophysiologic 
mechanisms [2, 4-6].
  
Herein, we demonstrated multimodal imaging (FA, 
ICGA, OCT, OCTA) features of a retinal MA in a patient 
with insulin-dependent diabetes mellitus (IDDM) and 




A 64-year-old female with IDDM presented with a 
gradual visual decline in both eyes (OU) and examined 
in October 2019 at Department of Ophthalmology 
(Dokuz Eylul University, İzmir, Turkey). Patient consent 
was obtained to write this case report. This study was 
performed in compliance with the principles of the 
Declaration of Helsinki. She had IDDM for 18 years 
with a recent HbA1c level of 6.2%. On admission, her 
best-corrected visual acuity with Snellen chart was 0.4 
in right eye (OD) and 0.5 in left eye (OS). Slit-lamp 
examination and intraocular pressure had normal 
findings in OU. A detailed fundus examination 
revealed multiple microaneurysms, blot hemorrhages 
and circinate exudates at the macula bilaterally. In 
addition, a MA was detected at the superior temporal 
area of the fovea in OD (Fig 1).  
FA showed multiple hyperfluorescent lesions in the 
early phase corresponding to microaneurysms in OU. 
In addition, a slow filling of large diameter 
hyperfluorescent lesion (A vertical diameter of about 
525 micrometers (μm) with no leakage was observed 
at the superior temporal area of the fovea in OD (Fig 
2A). Full lesion was noted to fill with dye at the 40th 
second of angiogram. Similarly, ICGA confirmed the 
presence of round shape hyperfluorescent lesion and 
full lesion could be filled at the 43th second of 
angiogram (Fig 2B).  
OCT scan of the right eye revealed an oval lesion 
corresponding to aneurysm. This lesion had a 
hyperreflective wall, containing partially 
hyperreflective lumen and back shadowing. Also, there 
was a thickened retina surrounding the MA, 
hyperreflective dots and serous subretinal fluid 
suggestive of inflammation (Fig 3A and B). OCTA 
showed a round-demarcated faded flow area at the 
level of superficial and deep capillary plexus (Fig 3C 
and D). Hypointense flow area corresponding to MA-
related back-shadowing was noted at the 
choriocapillaris slab (Fig 3E).  
Regarding these findings, severe non-proliferative DR, 
DME and DR-related MA were suggested. Although a 
combined treatment of direct focal argon laser 
photocoagulation onto the MA together with an 
intravitreal dexamethasone implant was recommended, 
but she denied any treatment due to reimbursement 





Figure 1. Fundus photographs of the right (A) and left eyes (B) showing venous dilatation blot hemorrhages, multiple microaneurysms and hard 
exudates. Fundus photograph of the right eye (A) illustrating macroaneurysm at the superior temporal area of the fovea (black arrow). 
 
 
Med Hypothesis Discov Innov Ophthalmol. 2020; 9(1)  
35 MULTIMODAL IMAGING CHARACTERISTICS OF   CAPILLARY MACROANEURYSM IN DIABETIC CASE 
 
 
Figure 2. Angiographic images of the right eye illustrating macroaneurysm lesion and its progressive filling in magnified frames. Fluorescein (A) and 
indocyanine green angiogram (B) showing hypofluorescence lesion in early phase and slow dye filling in late phase.   
 
 
Figure 3. Optical Coherence Tomography (OCT) B scan (A, B) and OCT-Angiography (OCTA) scans (C-E) of the right eye obtained from Triton™ DRI swept‐
source optical coherent tomography (SS‐OCT) instrument. OCT scan (B) passing through the macroaneurysm indicating an oval lesion (red arrow), with 
a hyperreflective wall, containing partially hyperreflective lumen, and back-shadowing, surrounded by intraretinal fluid. OCTA showing round-
demarcated faded flow area at the level of superficial (C) and deep (D) capillary plexus (yellow arrows). OCTA image at the level of choriocapillaris (E) 
illustrating hypointense flow area corresponding to MA-related back-shadowing (blue arrow). 
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DISCUSSION 
In this case presentation, comprehensive multimodal 
imaging features of a large retinal capillary MA were 
presented in a patient with IDDM and severe DME.  
DR-related MA was first described by Bourhis et al. [2]
 
Because the term ''macroaneurysms'' could cause 
confusion with an arterial MAs
 
[7-11], they 
recommended the use of ''telangiectatic capillaries''. Its 
prevalence and incidence remain still unknown in DR. 
They can develop from vessels including capillaries, 
arteries, veins or collaterals as a result of focal 
weakening of the vessel wall and endothelial cell 
proliferation [2].
 
Because of the severely defective site of 
the blood-retinal barrier, accumulation of large materials 
such as lipoproteins is prominent. MAs are more likely to 
be seen in areas close to the hard exudates [2, 4, 5].
 
In a 
series conducted by Castro Farías et al. [4], a significant 
correlation was found between the presence of MAs and 
severity of hard exudates. Similarly, Paques et al.
 
[5] 
reported that the capillary MAs are often located at the 
center of circinate hard exudates.
  
In the present case, 
the MA was closely associated with the circinate hard 
exudates as clearly depicted on the right color fundus 
picture and this clinical appearance is in accordance with 
aforementioned investigations.
 
MAs have diameters larger than 150 μm and localized 
very close to microaneurysms and share similar OCT and 
ICGA features [4, 5]. It is therefore suggested that MAs 
are originated from the microaneurysms [4, 12].
 
Although no clear-cut criteria have been identified to 
distinguish MAs and microaneurysms other than their 
size, some differentiating angiographic characteristics 
have been described. Microaneurysms show a bright 
contrast in the earlier phase, whereas no change in 
contrast size or brightness is observed in the later phase. 
By contrast, MAs often fill later than microaneurysms on 
the course of angiogram. Angiographic studies revealed a 
delayed or prolonged complete ICG filling. Also, 
fluorescence in MAs often persists longer in the ICGA 
examinations [2, 4, 5]. Similarly, our patient's angiogram 
showed early hypofluorescence of the MA with a 
relatively delayed complete dye filling. 
Progressive staining of intraluminal material (proteins 
and/or lipids) is suggested to be the cause of delayed or 
prolonged dye filling in ICGA. Histological studies have 
also shown that intraluminal materials such as lipids 
and/or stagnant blood and even thrombosis have a high 
affinity for staining with ICG [3].
 
ICG that may stain 
intraluminal fibrinogen due to amphiphilic properties is 
more sensitive than the sodium fluorescein for detection 
of capillary MAs. It was even reported that some of the 
lesions detected by ICGA were very faintly seen or could 
not be visualized by FA [2, 4, 5].
 
Moreover, MAs can be 
seen much better by OCT than FA. The characteristic OCT 
appearance of MAs is made up of the lumen with 
variable reflectivity due to different materials 
surrounded by a round hyperreflective wall. Cystic spaces 
can be easily distinguished from MAs as they are optically 
empty [2].
 
Although OCTA can demonstrate most of the 
microaneurysms
 
[6], large MAs may not be visualized 
paradoxically. This limitation is related to the OCTA's 
sensitivity. When the flow within the lesion is below the 
slowest value that can be detected by OCTA, it cannot be 
visualized on OCTA [13].
 
The decrease in blood flow due 
to the vessel wall thickening and intraluminal material 
accumulation has been considered as the cause of poor 
detection of MAs [4]. OCTA is therefore not a sufficient 
imaging technique for cases with MAs as in our case.
 
Since FA is routinely performed in eyes with DR, many 
MAs can be easily overlooked. Therefore, the presence of 
MAs cannot be recognized. MAs may not respond well 
enough to intravitreal anti- vascular endothelial growth 
factor treatments. Thermal laser photocoagulation has 
been reported to be more effective in these patients. 
ICG-guided laser photocoagulation for capillary MAs has 
been investigated by Paques et al. [5].
 
In this 
retrospective study, nine eyes with chronic macular 
edema and hard exudates due to DR (4 eyes) and RVO (5 
eyes) were included. The capillary MAs were 
demonstrated with OCT and ICGA and its median size 
was 410 µm (range, 158-603). While four patients had 
previously received treatment (intravitreal injections and 
grid laser) for macular edema, none received any 
treatment within the last 3 months prior to laser 
treatment. Capillary MAs were selectively 
photocoagulated using a 532 nm laser (spot size; 50 µm, 
duration; 0.2 s and power; 100 mW). Photothrombosis 
inside the lumen was assessed by OCT. Six months after 
the treatment, the authors reported a significant 
improvement in visual acuity (mean log MAR, 0.82 versus 
0.58) and reduction in macular edema (mean macular 
thickness, 528 versus 271). In our case, we planned to 
administer direct focal thermal laser photocoagulation 
onto the MA together with an intravitreal 
dexamethasone implant due to severe macular edema as 
also suggested in the literature but she unfortunately 
denied any treatment due to reimbursement issues.
 
 
Perifoveal exudative vascular anomalous complex 
(PEVAC) is a recently defined entity that should be 
considered in the differential diagnosis of retinal MAs, 
which occurs as a unilateral, isolated, perifoveal lesion. 
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Large aneurysmal dilatation, hard exudates, intraretinal 
hemorrhages and fluid accumulation are the common 
features of both entities. However, the pathogenesis is 
different. It is considered that PEVAC is resulted from 
progressive retinal endothelial cell degeneration. In 
addition, while telangiectatic capillaries usually occur in 
retinal vascular diseases such as retinal vein occlusion 
(RVO) and DR, PEVAC is reported in otherwise healthy 
subjects [14, 15]. The main limitation of this case 
presentation was lack of treatment and thereby possible 
treatment effect on MA and macular edema. However, 
we still believe that multimodal imaging characteristics of 
the present case with DR related MA were demonstrated 
in utmost detail.   
CONCLUSIONS 
Clinicians should look for the presence of MAs in patients 
with severe and chronic macular edema. In light of the 
present case and the literature review, we believe that 
FA, ICGA and OCT may be equally helpful for detection 
and visualizing the extent of MAs. The diagnostic criteria, 
treatment strategies and prognosis of DR-related MAs 
are not well-defined. We believe that the definitive 
diagnosis criteria, treatment alternatives and its 
prognosis will be better determined by further studies. 
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